Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

peanuts

Peanut allergies? There’s a clinical trial looking to fix that

October 17, 2017 Manufacturing and Production, Research and Development Aimmune, Regeneron, Sanofi, biotech, drugs, peanuts, pharma, pharmaceutical

Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration …
News
shutterstock_79370437

Asking the right questions: Measuring the impact of pharmacovigilance

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …
Feature
veeva

Simplify your regulatory processes

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …
News
prevail_-_ebola_vaccination

Trials reveal two strong vaccine candidates for Ebola

October 16, 2017 Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical

Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …
News
astrazeneca_plaque

AstraZeneca admits cancer data for acquired drug was fabricated

October 16, 2017 Research and Development, Sales and Marketing Acerta, AstraZeneca, acalabrutinib

AstraZeneca has revealed that early-stage data concerning the efficacy of its acquired drug acalabrutinib in the treatment of blood cancers …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, pharmaceuticals, top ten

It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …
News
nerves

Breakthrough study could revolutionise MS treatment

October 13, 2017 Medical Communications, Research and Development biotech, drugs, multiple sclerosis, pharma, pharmaceutical

The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from …
News
news

Free Webinar: EudraVigilance changes and the impact on MAHs

October 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.
News
microscope-275984_960_720

First leprosy vaccine makes initial step towards human use

October 13, 2017 Medical Communications, Research and Development biotech, drugs, leprosy, pharma, pharmaceutical

A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …
News
shutterstock_95714119

Strong IBS and constipation Phase 3 data sends Ardelyx shares rocketing 60%

October 12, 2017 Research and Development Ardelyx, pharma, pharmaceuticals, tenapanor

Ardelyx has confirmed that its NHE3 inhibitor tenapanor met all its primary and secondary endpoints in the study of its …
News
weight-2036971_960_720

Childhood obesity increased 10-fold over last four decades

October 11, 2017 Research and Development biotech, drugs, obese, obesity, pharma, pharmaceutical

An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …
News
shutterstock_254160583

Lupin scoops up women’s health specialist Symbiomix for $150 million

October 11, 2017 Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma

The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …
News
shutterstock_212432119

Moffitt scientists discover new applications for Novartis’s Zykadia

October 11, 2017 Research and Development Cancer, Moffitt, NSCLC, ceritinib, lung cancer, zykadia

Through the use of molecular screening, functional proteomics and computer-based modelling, researchers from the Moffitt Cancer Center have been working …
News
biocon-ltd-hebbagodi-bangalore-ukif4_web

Mylan and Biocon Neulasta biosimilar knocked back by FDA

October 11, 2017 Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta, biotech, drugs, pharma, pharmaceutical

Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …
News
allergan

Allergan settles gender discrimination case for $4m

October 11, 2017 Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026